A Comprehensive Overview of Epidemiology, Pathogenesis and the Management of Herpes Labialis
- PMID: 36680265
- PMCID: PMC9867007
- DOI: 10.3390/v15010225
A Comprehensive Overview of Epidemiology, Pathogenesis and the Management of Herpes Labialis
Abstract
Herpes labialis remains exceedingly prevalent and is one of the most common human viral infections throughout the world. Recurrent herpes labialis evolves from the initial viral infection by herpes simplex virus type 1 (HSV-1) which subsequently presents with or without symptoms. Reactivation of this virus is triggered by psychosocial factors such as stress, febrile environment, ultraviolet light susceptibility, or specific dietary inadequacy. This virus infection is also characterized by uninterrupted transitions between chronic-latent and acute-recurrent phases, allowing the virus to opportunistically avoid immunity and warrant the transmission to other vulnerable hosts simultaneously. This review comprehensively evaluates the current evidence on epidemiology, pathogenesis, transmission modes, clinical manifestations, and current management options of herpes labialis infections.
Keywords: antiviral agents; herpes labialis; management; prevention; treatments.
Conflict of interest statement
The authors declare no conflict of interest.
Similar articles
-
Human herpes simplex labialis.Clin Exp Dermatol. 2007 Nov;32(6):625-30. doi: 10.1111/j.1365-2230.2007.02473.x. Clin Exp Dermatol. 2007. PMID: 17953630 Review.
-
Longitudinal evaluation of herpes simplex virus DNA load during episodes of herpes labialis.J Clin Virol. 2006 Dec;37(4):248-51. doi: 10.1016/j.jcv.2006.09.006. J Clin Virol. 2006. PMID: 17046320 Clinical Trial.
-
Herpes simplex virus infection: part I--Biology, clinical presentation and latency.Refuat Hapeh Vehashinayim (1993). 2005 Jan;22(1):7-15, 84. Refuat Hapeh Vehashinayim (1993). 2005. PMID: 15786655
-
Calcium spirulan derived from Spirulina platensis inhibits herpes simplex virus 1 attachment to human keratinocytes and protects against herpes labialis.J Allergy Clin Immunol. 2016 Jan;137(1):197-203.e3. doi: 10.1016/j.jaci.2015.07.027. Epub 2015 Sep 2. J Allergy Clin Immunol. 2016. PMID: 26341274
-
Herpes simplex viruses 1 and 2.Dermatol Clin. 2002 Apr;20(2):249-66. doi: 10.1016/s0733-8635(01)00003-1. Dermatol Clin. 2002. PMID: 12120439 Review.
Cited by
-
Atopic Disease as a Risk Factor for Recurrent Herpetic Keratitis.Microorganisms. 2024 Jan 21;12(1):220. doi: 10.3390/microorganisms12010220. Microorganisms. 2024. PMID: 38276205 Free PMC article.
-
Evaluating the effectiveness of topical olive leaf extract emulgel in managing recurrent herpes labialis: a randomized controlled clinical study.Sci Rep. 2024 Dec 2;14(1):29989. doi: 10.1038/s41598-024-81805-0. Sci Rep. 2024. PMID: 39623211 Free PMC article. Clinical Trial.
-
Oral Pathogens' Substantial Burden on Cancer, Cardiovascular Diseases, Alzheimer's, Diabetes, and Other Systemic Diseases: A Public Health Crisis-A Comprehensive Review.Pathogens. 2024 Dec 9;13(12):1084. doi: 10.3390/pathogens13121084. Pathogens. 2024. PMID: 39770344 Free PMC article. Review.
-
Assessment of IL28 (rs12980275) and (rs8099917) Frequency in Recurrent Ocular Herpes Simplex Virus (HSV) Infection.Life (Basel). 2025 Mar 1;15(3):389. doi: 10.3390/life15030389. Life (Basel). 2025. PMID: 40141734 Free PMC article.
-
Tackling cutaneous herpes simplex virus disease with topical immunomodulators-a call to action.Clin Microbiol Rev. 2025 Mar 13;38(1):e0014724. doi: 10.1128/cmr.00147-24. Epub 2025 Feb 21. Clin Microbiol Rev. 2025. PMID: 39982077 Review.
References
-
- Herpes & Shingles: Symptoms & Treatments—Life Extension. [(accessed on 19 September 2021)]. Available online: https://www.lifeextension.com/protocols/infections/herpes-and-shingles.
-
- Billions Worldwide Living with Herpes. [(accessed on 9 May 2022)]. Available online: https://www.who.int/news/item/01-05-2020-billions-worldwide-living-with-....
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical